SEC Form 4 · accession 0001192482-17-000111
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sol J Barer
Director
Period of report
Apr 28, 2017
Accepted (ET)
May 1, 2017 · 9:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 28, 2017 | P | 100,000 | $1.5667 | A | 607,000 | D | |
| Common StockF1 | holding | — | — | — | 153,846 | I | By: Wife | |
| Common StockF2 | holding | — | — | — | 365,854 | I | By: grantor retained annuity trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares purchased by the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F2By the Sol J. Barer 2013 Grantor Retained Annuity Trust No. IV.